|
ABSTRACT
Title |
: |
Poverty, Affordability of Anti-Diabetic Drugs and Glycemic Control: An Unholy Alliance in a Developing Economy? |
Authors |
: |
Giwa Abdulganiyu, Tayo Fola |
Keywords |
: |
Poverty, Affordability, Glycemic-Control, Socio-Economic Status, Unholy Alliance, Pharmaco-Economics |
Issue Date |
: |
September 2013 |
Abstract |
: |
Purpose: To determine the Relationship between Poverty, Affordability of Anti-Diabetic Drugs and Glycemic Control in a Developing Economy in 2010.
Methods: A crossectional study using questionnaire to assess World Bank socio-economic indicators of poverty for each subject and information from prescriptions and case-notes about affordability and glycemic control respectively was conducted and evaluated. Sample Size, n=1200. Subjects were selected by systematic random sampling (Sampling Interval = 1).
Results: Majority (93.8%) of the poor subjects could not afford at-least one anti-diabetic drug. Most (98.6%) of the non-poor subjects could afford all available prescribed anti-diabetic drugs. Poor and non-poor subjects significantly differ in affordability of anti-diabetic drugs (?2 =169.7, df = 1, p = 0.000). Majority (67.4%) of the poor subjects had poor glycemic control. Three hundred and fifty six (81.3%) of the non-poor subjects had good glycemic control. Poor and non-poor subjects significantly differ in glycemic control (2 = 128.77; df = 2; p = 0.000). Majority (83.3%) of the subjects that could afford all available prescribed anti-diabetic drugs had good glycemic control. Five hundred and twenty (72.1%) of the subjects that could not afford at-least one of the available prescribed anti-diabetic drugs had poor glycemic control. Subjects that could afford all their drugs and those who could not, significantly differ in glycemic control (2 = 154.86; df = 2; p = 0.000).
Conclusions: Poverty is an hindrance to good glycemic control in terms of anti-diabetics purchase (nonaffordability) |
Page(s) |
: |
113-120 |
ISSN |
: |
0975-9492 |
Source |
: |
Vol. 4, No.9 |
|